Get the Stockscreener App
9.33
1.86%
0.17
After Hours:
9.20
-0.13
-1.39%
Pavmed Inc stock is traded at $9.33, with a volume of 19,334.
It is up +1.86% in the last 24 hours and down -8.53% over the past month.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
See More
Previous Close:
$9.16
Open:
$9.32
24h Volume:
19,334
Relative Volume:
0.02
Market Cap:
$58.92M
Revenue:
$71,000
Net Income/Loss:
$-2.47M
P/E Ratio:
-0.2835
EPS:
-32.9143
Net Cash Flow:
$-5.24M
1W Performance:
-5.18%
1M Performance:
-8.53%
6M Performance:
-41.46%
1Y Performance:
-56.52%
1-Day Range:
$9.10
$9.45
1-Week Range:
$9.05
$9.7532
52-Week Range:
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Name
Pavmed Inc
Sector
Industry
Phone
(212) 949-4319
Address
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
9.33 | 57.85M | 71,000 | -2.47M | -5.24M | -32.91 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-05-20 | Initiated | Ascendiant Capital Markets | Buy |
| Jun-28-18 | Initiated | Maxim Group | Buy |
Pavmed Inc Stock (PAVM) Latest News
Dana Carrera, Tasso Partners disclose 15.3% stake in PAVmed (NASDAQ: PAVM) - Stock Titan
70,000-share PAVmed (PAVM) restricted stock grant to CMO - Stock Titan
[Form 3] PAVmed Inc. Initial Statement of Beneficial Ownership - Stock Titan
Scopia Holdings/Member Matthew Sirovich reports 9.99% in PAVmed (PAVM) - Stock Titan
Risk Report: Is PAVmed Inc forming higher highs and higher lows2026 Technicals & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - Quantisnow
PAVmed (PAVM) price target decreased by 16.51% to 268.26 - MSN
Treasury Yields: Is PAVmed Inc a potential multi bagger2026 Summary & High Return Trade Guides - baoquankhu1.vn
Aug Reactions: Can PAVmed Inc expand into new markets2026 Snapshot & Weekly Stock Performance Updates - baoquankhu1.vn
Lishan Aklog Discloses Investment at PAVmed Inc. with 5.1% Stake - TradingView — Track All Markets
PAVmed (PAVM) CEO Aklog reports 5.1% stake and 350,000 restricted shares - Stock Titan
Lucid Diagnostics CEO to Participate in Healthcare Conference - Intellectia AI
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - Barchart.com
Entry Recap: Can PAVmed Inc be recession proofQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst Reassessment - Yahoo Finance
Nagelberg disclosures show 8.6% ownership in PAVmed (NASDAQ: PAVM) - Stock Titan
Aug PostEarnings: Can PAVmed Inc sustain its profitability2026 Growth vs Value & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
PAVmed (NASDAQ: PAVM) Scott Dols reports 5.4% stake, 346,155 shares - Stock Titan
PAVM Appoints Joseph Virgilio to Oversee Revamp of Medical Device Portfolio - Bitget
PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio Relaunch - Yahoo Finance
Tasso Partners, LLC (PAVM) reports large PAVmed stake and warrant position - Stock Titan
EV Market: Will PAVmed Inc benefit from rate cuts2026 Price Targets & Weekly Return Optimization Alerts - baoquankhu1.vn
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Big Money Moves: Whats next for PAVmed Inc stockBuy Signal & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
PAVM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
PAVmed (PAVM) CEO Lishan Aklog awarded 350,000 restricted shares vesting 2029 - Stock Titan
Craig Kallman (PAVM) holds 384,616 shares, a 6.0% stake in PAVmed - Stock Titan
PAVmed (PAVM) CFO awarded 180,000 restricted shares vesting 2029 - Stock Titan
Director at PAVmed (PAVM) receives 13,930 restricted stock shares - Stock Titan
PAVmed (PAVM) director Timothy Baxter receives 13,930 restricted shares vesting in 2029 - Stock Titan
Restricted stock grant boosts PAVmed (PAVM) director’s holdings - Stock Titan
PAVmed (PAVM) director gets 13,930-share restricted stock grant - Stock Titan
Restricted stock award boosts PAVmed (NASDAQ: PAVM) director stake - Stock Titan
Tasso Partners and Dana Carrera disclose 14.3% stake in PAVmed (PAVM) - Stock Titan
PAVmed (PAVM) general counsel receives 110,000-share restricted award - Stock Titan
PAVmed (PAVM) COO receives 110,000-share restricted stock grant vesting 2029 - Stock Titan
Lucid Diagnostics Inc. (LUCD) stock price, news, quote and history - Yahoo Finance UK
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - Bitget
PAVmed appoints Joseph Virgilio as medical device chief By Investing.com - Investing.com Australia
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed Appoints New Executive to Drive Medical Device Development - Intellectia AI
PAVmed: Octeris, Inc. Subsidiary Formed to Advance Endoscopic Esophageal Imaging Tech Recently Licensed From Duke University >PAVM - Moomoo
PAVmed appoints Joseph Virgilio as medical device chief - Investing.com
PAVmed Inc. (NASDAQ:PAVM) Q4 2025 Earnings Call Transcript - Insider Monkey
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Cuts Target Price to $16 - Moomoo
PAVmed Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Fundamentals Check: Is PAVmed Inc a potential multi baggerWeekly Profit Recap & High Conviction Buy Zone Picks - baoquankhu1.vn
PAVmed completes $45M financing, eliminates convertible debt By Investing.com - Investing.com Australia
PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN
PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Re - GuruFocus
Pavmed Inc Stock (PAVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):